Patterns of Specific Antimigraine Drug use – A Study Based on the Records of 18 Community Pharmacies
- 1 March 2005
- journal article
- Published by SAGE Publications in Cephalalgia
- Vol. 25 (3), 214-218
- https://doi.org/10.1111/j.1468-2982.2004.00843.x
Abstract
The objective of this study was, first, to characterize the usage patterns of specific antimigraine drugs, and second, to compare these in patients with one type of drug with patients with two or more types of drug. Dispensing data on triptans and ergotamine were collected from community pharmacy records over a 1-year period. In a population of approximately 168 000 specific antimigraine medication has been dispensed to 2343 patients (1.4%). Oral dosage forms were prescribed in most prescriptions (77.1%), subcutaneous injections in 9.7%, rectal suppositories in 7.1% and nasal sprays in 6.1%. We identified 292 patients (12.5%) to whom more than one type of drug was dispensed. Multiple drugs patients showed significantly higher drug consumption and deviating patterns of specific antimigraine drug usage, receiving significantly more non-oral dosage forms (32.8% vs. 20.4%, P < 0.001). Our data indicate substantially suboptimal treatment of migraine patients.Keywords
This publication has 10 references indexed in Scilit:
- Memory problems after epilepsy surgeryNeurology, 2003
- Single Use of Sumatriptan: A Patient Interview StudyHeadache: The Journal of Head and Face Pain, 2003
- Features of medication overuse headache following overuse of different acute headache drugsNeurology, 2002
- Migraine — Current Understanding and TreatmentThe New England Journal of Medicine, 2002
- Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trialsThe Lancet, 2001
- Patterns of Ergotamine and Sumatriptan Use in the Netherlands from 1991 to 1997Cephalalgia, 2001
- The impact of migraine on quality of life in the general populationNeurology, 2000
- Migraine, quality of life, and depressionNeurology, 2000
- The economic burden of migraine to society.PharmacoEconomics, 1998
- Use of sumatriptan in Denmark in 1994–5: an epidemiological analysisof nationwide prescription dataBritish Journal of Clinical Pharmacology, 1997